Literature DB >> 3397187

Differences in virulence for mice among strains of Mycoplasma pulmonis.

M K Davidson1, J R Lindsey, R F Parker, J G Tully, G H Cassell.   

Abstract

The mouse model of acute murine respiratory mycoplasmosis was used to screen 18 strains of Mycoplasma pulmonis for their ability to establish respiratory infections and produce gross lung lesions in the susceptible C3H/HeN mouse strain. All experiments were designed to minimize host, environmental, and microbial differences to ensure that experimental results would reflect differences in mycoplasmal virulence. There were differences in the 50% infectious dose (range, 3 X 10(2) to greater than 10(7) CFU) and the 50% gross pneumonia dose (range, 10(3) to greater than 10(7) CFU) among the 18 mycoplasmal strains. Only 10 strains (UAB CT, M1, UAB 5782C, UAB 6510, 66, UAB T, UAB 8145D, Nelson C, Peter C, and Negroni) established respiratory infections, and only 2 of the 10 strains (UAB CT and M1) produced gross lung lesions. Strains UAB CT, UAB T, M1, UAB 5782C, and PG34(ASH) were chosen for qualitative and quantitative evaluation of lung lesions in C3H/HeN and C57BL/6N mice. Lesion incidence and severity was dependent on the mycoplasmal strain and the mouse strain. Microscopic lesions varied among mycoplasmal strains and mouse strains in the amount of lymphoid infiltrate, neutrophilic exudate, and consolidation, as well as overall severity. The most virulent strain, UAB CT, produced acute pneumonitis in the 10(7) CFU dosage group and required a threshold dose of 10(3) CFU to consistently produce microscopic lung lesions. These results suggest that M. pulmonis virulence is multifactorial and different strains of mycoplasmas yield disease expressions that differ both qualitatively and quantitatively.

Entities:  

Mesh:

Year:  1988        PMID: 3397187      PMCID: PMC259538          DOI: 10.1128/iai.56.8.2156-2162.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Variation in the virulence of strains of Mycoplasma pulmonis related to susceptibility to killing by macrophages in vivo.

Authors:  C J Howard; G Taylor
Journal:  J Gen Microbiol       Date:  1979-10

2.  Detection of antibodies to Mycoplasma pulmonis by an enzyme-linked immunosorbent assay.

Authors:  S A Horowitz; G H Cassell
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

3.  Synergistic effect of Sendai virus on Mycoplasma pulmonis infection in mice.

Authors:  M Saito; M Nakagawa; E Suzuki; K Kinoshita; K Imaizumi
Journal:  Nihon Juigaku Zasshi       Date:  1981-02

4.  Strain difference of mouse in susceptibility to Mycoplasma pulmonis infection.

Authors:  M Saito; M Nakagawa; T Muto; K Imaizumi
Journal:  Nihon Juigaku Zasshi       Date:  1978-12

5.  The role of environmental ammonia in respiratory mycoplasmosis of rats.

Authors:  J R Broderson; J R Lindsey; J E Crawford
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

6.  Murine respiratory mycoplasmosis in F344 and LEW rats: evolution of lesions and lung lymphoid cell populations.

Authors:  J K Davis; R B Thorp; P A Maddox; M B Brown; G H Cassell
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract.

Authors:  J R Lindsey; H Cassell
Journal:  Am J Pathol       Date:  1973-07       Impact factor: 4.307

8.  Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model.

Authors:  G H Cassell
Journal:  Rev Infect Dis       Date:  1982 May-Jun

9.  Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes.

Authors:  G Taylor; C J Howard
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

10.  Mycoplasmal adherence with particular reference to the pathogenicity of Mycoplasma pulmonis.

Authors:  D Taylor-Robinson; P M Furr; H A Davies; R J Manchee; C Mouches; J M Bove
Journal:  Isr J Med Sci       Date:  1981-07
View more
  28 in total

1.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Gene transfer in Mycoplasma pulmonis.

Authors:  Amy M Teachman; C Todd French; Huilan Yu; Warren L Simmons; Kevin Dybvig
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

3.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Angiopoietin-2-driven vascular remodeling in airway inflammation.

Authors:  Sebastien P Tabruyn; Katharine Colton; Tohru Morisada; Jonas Fuxe; Stanley J Wiegand; Gavin Thurston; Anthony J Coyle; Jane Connor; Donald M McDonald
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

5.  Secretory immune responses to Mycoplasma pulmonis.

Authors:  M J Steffen; J L Ebersole
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

6.  Surfactant dysfunction in SP-A-/- and iNOS-/- mice with mycoplasma infection.

Authors:  Judy M Hickman-Davis; Zhengdong Wang; German Alejandro Fierro-Perez; Patricia R Chess; Grier P Page; Sadis Matalon; Robert H Notter
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-17       Impact factor: 6.914

7.  Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection.

Authors:  Judy M Hickman-Davis; Carmel McNicholas-Bevensee; Ian C Davis; He-Ping Ma; Glenda C Davis; Charles A Bosworth; Sadis Matalon
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

8.  Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.

Authors:  C B Faulkner; J W Simecka; M K Davidson; J K Davis; T R Schoeb; J R Lindsey; M P Everson
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.